Cargando…
Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study
The main objective of the study is to assess whether there is an increased risk of mortality in the days following the administration of COVID-19 vaccines in Bologna Health Authority in the first year of COVID-19 vaccination campaign. A secondary objective was to describe causes of deaths occurred i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393158/ https://www.ncbi.nlm.nih.gov/pubmed/36038407 http://dx.doi.org/10.1016/j.vaccine.2022.08.039 |
_version_ | 1784771209487974400 |
---|---|
author | Stivanello, Elisa Beghelli, Chiara Cardoni, Francesco Giansante, Chiara Marzaroli, Paolo Musti, Muriel Assunta Perlangeli, Vincenza Todeschini, Renato Pandolfi, Paolo |
author_facet | Stivanello, Elisa Beghelli, Chiara Cardoni, Francesco Giansante, Chiara Marzaroli, Paolo Musti, Muriel Assunta Perlangeli, Vincenza Todeschini, Renato Pandolfi, Paolo |
author_sort | Stivanello, Elisa |
collection | PubMed |
description | The main objective of the study is to assess whether there is an increased risk of mortality in the days following the administration of COVID-19 vaccines in Bologna Health Authority in the first year of COVID-19 vaccination campaign. A secondary objective was to describe causes of deaths occurred in the days after vaccination. We conducted a retrospective observational study on all residents of Bologna Health Authority who received at least one COVID-19 vaccination dose from December 27, 2020 to December 31, 2021 and compared mortality in the 3, 7, 14 30 days after vaccination (risk interval) with the mortality in the period of the same length (3, 7, 14 and 30 days) beyond the 30th day after the last dose of vaccination (control interval). The cohort included 717,538 people. The mortality rate was 2.24 per 100 person-years during the 30 days risk interval vs 2.72 in the control interval with an adjusted incidence rate ratio equal to 0.76 (95% CI: 0.70–0.83, p < 0.001). The risk of mortality is significantly lower (p < 0.001) also in the 3, 7, 14 days risk intervals than in the control intervals. This study shows that there is no increase in mortality in the short-term period after COVID-19 vaccines. |
format | Online Article Text |
id | pubmed-9393158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93931582022-08-22 Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study Stivanello, Elisa Beghelli, Chiara Cardoni, Francesco Giansante, Chiara Marzaroli, Paolo Musti, Muriel Assunta Perlangeli, Vincenza Todeschini, Renato Pandolfi, Paolo Vaccine Article The main objective of the study is to assess whether there is an increased risk of mortality in the days following the administration of COVID-19 vaccines in Bologna Health Authority in the first year of COVID-19 vaccination campaign. A secondary objective was to describe causes of deaths occurred in the days after vaccination. We conducted a retrospective observational study on all residents of Bologna Health Authority who received at least one COVID-19 vaccination dose from December 27, 2020 to December 31, 2021 and compared mortality in the 3, 7, 14 30 days after vaccination (risk interval) with the mortality in the period of the same length (3, 7, 14 and 30 days) beyond the 30th day after the last dose of vaccination (control interval). The cohort included 717,538 people. The mortality rate was 2.24 per 100 person-years during the 30 days risk interval vs 2.72 in the control interval with an adjusted incidence rate ratio equal to 0.76 (95% CI: 0.70–0.83, p < 0.001). The risk of mortality is significantly lower (p < 0.001) also in the 3, 7, 14 days risk intervals than in the control intervals. This study shows that there is no increase in mortality in the short-term period after COVID-19 vaccines. Elsevier Ltd. 2022-09-16 2022-08-22 /pmc/articles/PMC9393158/ /pubmed/36038407 http://dx.doi.org/10.1016/j.vaccine.2022.08.039 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Stivanello, Elisa Beghelli, Chiara Cardoni, Francesco Giansante, Chiara Marzaroli, Paolo Musti, Muriel Assunta Perlangeli, Vincenza Todeschini, Renato Pandolfi, Paolo Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study |
title | Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study |
title_full | Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study |
title_fullStr | Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study |
title_full_unstemmed | Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study |
title_short | Short-term mortality following COVID-19 vaccination in Bologna, Italy: a one-year study |
title_sort | short-term mortality following covid-19 vaccination in bologna, italy: a one-year study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393158/ https://www.ncbi.nlm.nih.gov/pubmed/36038407 http://dx.doi.org/10.1016/j.vaccine.2022.08.039 |
work_keys_str_mv | AT stivanelloelisa shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy AT beghellichiara shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy AT cardonifrancesco shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy AT giansantechiara shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy AT marzarolipaolo shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy AT mustimurielassunta shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy AT perlangelivincenza shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy AT todeschinirenato shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy AT pandolfipaolo shorttermmortalityfollowingcovid19vaccinationinbolognaitalyaoneyearstudy |